Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Nigella Sativa in Children With House Dust Mite-Induced Respiratory Allergy Receiving Immunotherapy

NCT05450289 is registered in ClinicalTrials.gov with Universitas Airlangga as lead sponsor.

NCT NCT05450289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05450289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Nigella Sativa in Children With House Dust Mite-Induced Respiratory Allergy Receiving Immunotherapy
Lead sponsor
Universitas Airlangga
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2022
Completion date
May 31, 2023
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

house dust mite allergy